자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to evaluate the benefits of using it versus the risks to the fetus. Doctors don't have enough data to make unambiguous recommendations, but can provide information about risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, and those who did not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was accurate and to eliminate any bias.

The study of the researchers was not without its limitations. Researchers were unable in the beginning, to separate the effects of the medication from the disorder. This limitation makes it difficult for researchers to determine whether the few associations observed between the exposed groups were due to medication use, or if they were affected by the presence of comorbidities. Additionally the study did not examine the long-term effects of offspring on their parents.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases did not appear to be affected by the kind of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both mother and child of continuing treatment for the woman's condition. Doctors should discuss with their patients about this issue and, if possible, help them develop coping skills that can lessen the impact of her disorder in her daily life and relationships.

Interactions with Medication

Doctors are increasingly confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. These decisions are often made without clear and reliable evidence. Instead, doctors have to take into account their own experience in conjunction with the experiences of other physicians and the research on the subject.

Particularly, the subject of potential risks to the baby can be tricky. A lot of studies on this issue are based on observational data instead of controlled research and their findings are often contradictory. The majority of studies restrict their analysis to live births, which can underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

Conclusion A few studies have shown an association between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. The majority of studies show an unintended, or somewhat negative, impact. In every case, a careful analysis of the potential risks and benefits is required.

It isn't easy, but not impossible for women suffering from ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can a doctor prescribe adhd medication without a diagnosis increase depression, feelings of isolation, and family conflict for those suffering from the disorder. The loss of medication can also impact the ability to drive safely and to perform work-related tasks which are crucial aspects of daily life for those with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy educate family members, coworkers, and acquaintances about the condition, its effects on daily functioning, and the benefits of continuing the current treatment plan. Educating them can also aid in ensuring that the woman feels supported as she struggles with her decision. It is also worth noting that certain drugs can pass through the placenta therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug could be passed on to the baby.

Birth Defects and Risk of

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (Adhd Medication Prescription Uk), increases the concern over the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers utilized two massive datasets to analyze over 4.3 million pregnancies and determine if the use of stimulant medications caused birth defects. While the overall risk remains low, the scientists did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The researchers behind the study found no association between the use of early medications and other congenital anomalies, such as facial clefting or club foot. The results are in line with previous studies that showed an insignificant, but small increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. This risk increased during the latter part of pregnancy, when many women decide to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely need a caesarean, have an insufficient Apgar after birth and have a baby that needed breathing assistance when they were born. The researchers of the study were not able to eliminate selection bias because they restricted the study to women with no other medical conditions that could have contributed to the findings.

The researchers hope their research will aid in the clinical decisions of doctors who encounter pregnant women. The researchers recommend that, while discussing risks and benefits are important, the decision about whether to continue or stop medication should be made according to the severity of each woman's ADHD symptoms and her needs.

The authors also caution that while discontinuing the medications is an option, it isn't an option that is recommended due to the high incidence of depression and other mental health issues for women who are expecting or who are recently postpartum. Additionally, research suggests that women who stop taking their medications will have a tough transitioning to life without them once the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD are often faced with a number of difficulties when they must manage their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to a new routine. This is why many women elect to continue taking their strattera adhd medication medications throughout pregnancy.

The risk for nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. However, the amount of medication exposure to the infant can differ based on dosage, how often it is administered, and the time of day the medication is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't yet fully understood.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult decision for the woman who must weigh the benefits of her medication against the risks to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their most common adhd medication uk medication without risk during pregnancy and breast-feeding. As a result, more and more patients choose to do so, and in consultation with their physician, they have discovered that the benefits of maintaining their current medication exceed any risk.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and the underlying disorder Learn about the available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration, and, if necessary modifications to the medication regimen.